Showing 19,541 - 19,560 results of 46,952 for search '(( 5 ((wt decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 1.10s Refine Results
  1. 19541
  2. 19542

    DataSheet_1_Effects of arbuscular mycorrhizal fungi on the reduction of arsenic accumulation in plants: a meta-analysis.docx by Shangyan Hao (16400463)

    Published 2024
    “…<p>Arsenic (As) accumulation in plants is a global concern. Although the application of arbuscular mycorrhizal fungi (AMF) has been suggested as a potential solution to decrease As concentration in plants, there is currently a gap in a comprehensive, quantitative assessment of the abiotic and biotic factors influencing As accumulation. …”
  3. 19543
  4. 19544
  5. 19545

    Data Sheet 1_Oral immunotherapy for cow’s milk allergy in children: a systematic review and meta-analysis.docx by Yan Wang (15435)

    Published 2025
    “…Tolerance threshold at oral food challenges (OFC) increased following oral immunotherapy compared with a standard mean difference (SMD) of 3.58 (2.82–4.33). After oral immunotherapy, the antibody titers of cow milk protein sIgE (SMD -0.42, 95% CI: -0.72 to -0.11, I²=28.8%) and casein sIgE (SMD -0.54, 95% CI: -0.97 to -0.11, I²=0%) decreased. …”
  6. 19546
  7. 19547

    Datasheet1_Efficacy and safety of levetiracetam vs. oxcarbazepine in the treatment of children with epilepsy: a systematic review and meta-analysis.csv by Yuanyuan Liu (136992)

    Published 2024
    “…LEV and OXC monotherapy was not statistical different among children with epilepsy in seizure-free rate (relative risk [RR] = 1.010, 95% confidence interval [CI] [0.822, 1.242], P > 0.05) and seizure frequency decrease of ≥50% compared with baseline [RR = 0.938, 95% CI (0.676, 1.301), P > 0.05]. …”
  8. 19548

    Datasheet2_Efficacy and safety of levetiracetam vs. oxcarbazepine in the treatment of children with epilepsy: a systematic review and meta-analysis.pdf by Yuanyuan Liu (136992)

    Published 2024
    “…LEV and OXC monotherapy was not statistical different among children with epilepsy in seizure-free rate (relative risk [RR] = 1.010, 95% confidence interval [CI] [0.822, 1.242], P > 0.05) and seizure frequency decrease of ≥50% compared with baseline [RR = 0.938, 95% CI (0.676, 1.301), P > 0.05]. …”
  9. 19549
  10. 19550
  11. 19551

    Ablation study results. by Chunming Wen (17616274)

    Published 2025
    “…The computational cost decreased from 11.6 GFlops to 6.6 GFlops.</p></div>…”
  12. 19552

    LSDED structure. by Chunming Wen (17616274)

    Published 2025
    “…The computational cost decreased from 11.6 GFlops to 6.6 GFlops.</p></div>…”
  13. 19553

    SSFF and TFE structural diagrams. by Chunming Wen (17616274)

    Published 2025
    “…The computational cost decreased from 11.6 GFlops to 6.6 GFlops.</p></div>…”
  14. 19554

    Comparison of key data before and after pruning. by Chunming Wen (17616274)

    Published 2025
    “…The computational cost decreased from 11.6 GFlops to 6.6 GFlops.</p></div>…”
  15. 19555

    Improved structure of YOLO11. by Chunming Wen (17616274)

    Published 2025
    “…The computational cost decreased from 11.6 GFlops to 6.6 GFlops.</p></div>…”
  16. 19556

    3-D comparison of key data across models. by Chunming Wen (17616274)

    Published 2025
    “…The computational cost decreased from 11.6 GFlops to 6.6 GFlops.</p></div>…”
  17. 19557
  18. 19558

    Shape-IoU structure diagram. by Chunming Wen (17616274)

    Published 2025
    “…The computational cost decreased from 11.6 GFlops to 6.6 GFlops.</p></div>…”
  19. 19559

    YOLO11 structure. by Chunming Wen (17616274)

    Published 2025
    “…The computational cost decreased from 11.6 GFlops to 6.6 GFlops.</p></div>…”
  20. 19560

    Comparative experimental results. by Chunming Wen (17616274)

    Published 2025
    “…The computational cost decreased from 11.6 GFlops to 6.6 GFlops.</p></div>…”